The results showed that IGF2BP2, PLAU, and CEP55 were found to be statistically significantly higher expressed in tumours than in normal samples, while CMYA5 was statistically significantly lower expressed in tumours. This evidence concerns the gene IGF2BP2 and neoplasm.